<DOC>
	<DOCNO>NCT00600769</DOCNO>
	<brief_summary>Use oral clarithromycin treatment chronic lung disease due Mycobacterium avium-intracellulare non-tuberculous Mycobacteria</brief_summary>
	<brief_title>Clarithromycin Treatment Infections Caused Nontuberculous Mycobacteria ( NTM )</brief_title>
	<detailed_description />
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Meet American Thoracic Society criterion nontuberculous lung disease : two AFB smear positive , culture positive sputum bronchoscopic sample and/or two AFB smear negative respiratory sample moderate heavy growth ( 2+4+ ) ; abnormal CXR consistent M. avium lung disease ; absence potential lung pathogen ( except coexistence M. abscessus ) Age 18 year old History macrolide allergy Must receive antihistamine terfenadine ( Seldane ) astemizole ( Hismanal ) clarithromycin Children le 18 year age If menstruating female , pregnant adequate birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>MAC</keyword>
	<keyword>NTM</keyword>
</DOC>